Beta-Catenin Positive Giant Cell Tumor of Bone with Pathological Fracture Treated with Neoadjuvant Denosumab Therapy for Visualizing Extraskeletal Lesions
Neoadjuvant denosumab therapy is an effective approach for managing β-catenin positive GCTB with pathological fractures as it promotes intratumoral ossification and facilitates complete resection of GCTB, including extraskeletal lesions.
Authors
- Yoichi Kaneuchi (ORCID: https://orcid.org/0000-0002-6682-8236)
- Michiyuki Hakozaki (ORCID: https://orcid.org/0000-0003-1641-0795)
- Shunsuke Sato (ORCID: https://orcid.org/0000-0002-7480-7283)
- Takuya Nikaido (ORCID: https://orcid.org/0000-0002-8162-9294)
- Yoshihiro Matsumoto (ORCID: https://orcid.org/0000-0002-0039-2855)
- Shoki Yamada
- Osamu Hasegawa
- Itaru Ogawa
- Takeo Suzuki
Institutions
- Fukushima Medical University (JP)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1159/000546985
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00